表紙
市場調查報告書
商品編碼
1088274

ECMO(體外膜氧合)全球市場2022-2030年:市場規模(模式,應用,患者人口統計),區域前景,增長潛力,市場份額,預測

Extracorporeal Membrane Oxygenation Market Size By Modality, By Application, By Patient Population, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030

出版日期: | 出版商: Global Market Insights Inc. | 英文 154 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

由於心肺疾病和呼吸衰竭病例的增加,預計到 2030 年 ECMO(體外膜氧合)市場將顯著增長。

越來越多的傳染病以及對 ECMO 設備各種好處的日益認識也可能推動未來幾年的市場增長。

從應用來看,2021年呼吸領域市場佔有率將超過65.0%,慢性阻塞性肺病(COPD)等呼吸系統疾病患者對呼吸輔助設備的需求量將猛增,因此,預計在預測期內顯著增長。

本報告調查了全球 ECMO(體外膜氧合)市場,定義和概述了市場,分析了對市場增長、法律和監管環境以及市場規模的變化和預測的各種影響因素,按類別/地區細分/主要國家、競爭環境、主要公司概況等。

目錄

第一章調查方法

第2章執行摘要

第3章ECMO(體外膜氧合)行業考量

  • 行業分類
  • 產業情況
  • 行業影響因素
    • 生長因子
    • 行業的潛在風險和挑戰
  • 增長潛力分析
  • COVID-19:影響分析
  • 監管狀態
  • ECMO治療劑量:按地區
  • 波特分析
  • 競爭形勢
  • PESTEL 分析

第 4 章 ECMO(體外膜氧合)市場:按模式

  • 主要趨勢
  • 靜動脈 (VA)
  • 靜靜脈(VV)
  • 動脈和靜脈 (AV)

第 5 章 ECMO(體外膜氧合)市場:按應用分類

  • 主要趨勢
  • 心髒病
  • 呼吸系統疾病
  • 體外心肺復蘇術 (ECPR)

第 6 章 ECMO(體外膜氧合)市場:按患者組分類

  • 主要趨勢
  • 蹣跚學步的孩子
  • 兒童
  • 成人

第 7 章 ECMO(體外膜氧合)市場:按地區劃分

  • 主要趨勢
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第 8 章公司簡介

  • 競爭性儀表板
  • Abbott Laboratories
  • Fresenius Medical Care AG & Co. KGaA
  • Braile Biomedica
  • Edwards Lifesciences Corporation
  • ABIOMED
  • EUROSETS
  • Getinge AB
  • LivaNova PLC
  • Medtronic
  • MicroPort Scientific Corporation
  • NIPRO
  • SB-KAWASUMI LABORATORIES, INC
  • Spectrum Medical
  • Terumo Corporation
目錄
Product Code: 2720

The extracorporeal membrane oxygenation (ECMO) market is speculated to grow massively by 2030 owing to increasing cases of cardiopulmonary diseases and respiratory failures. In addition, rising prevalence of infectious diseases, along with surging awareness of various benefits of ECMO devices, are likely to augment market growth in the forthcoming years.

During the COVID-19 pandemic, the market witnessed an exponential demand due to the growing requirement for extra life support systems for critically ill patients. Notably, favorable government policies and supportive investments in the ECMO sector have further boosted market revenue. For instance, in May 2022, North Collier Hospital (NCH) Healthcare System, a non-profit healthcare system in Naples, Florida, invested heavily in ECMO machines to provide extra life support to heart patients. NCH stated that it was equipped to provide 8 ECMO patients with a few hours or weeks of support at a time.

Moreover, major players in the industry are actively participating in product innovation and technological advancements to maintain a prominent position in the ECMO market, thereby positively impacting the product landscape. For instance, in August 2020, Terumo Cardiovascular, a medical device company, collaborated with CytoSorbents, a critical care immunotherapy expert, for the sale of CytoSorb to hospitals across ten COVID-19 hotspot states in the U.S. for use in critically ill, adult patients with confirmed or imminent respiratory failure.

The extracorporeal membrane oxygenation (ECMO) market has been divided in terms of patient population, modality, application, and region.

Based on modality, the ECMO industry has been divided into veno-venous (VV), venoarterial (VO), and arteriovenous (AV). The veno-venous (VV) segment is expected to witness growth at around 1.9% CAGR through the analysis period. The growth is attributed to the noteworthy benefits of VV, such as temporary lung assistance and cardiopulmonary support delivered to patients.

With reference to application, the extracorporeal membrane oxygenation (ECMO) market has been split into extracorporeal cardiopulmonary resuscitation (ECPR), cardiac, and respiratory. The respiratory application segment held over 65.0% market share in 2021 and is slated to progress remarkably through the forecast period as a result of booming demand for respiratory assistance devices for patients suffering from respiratory illnesses like chronic obstructive pulmonary disease (COPD).

With regards to patient population, the ECMO industry has been categorized into adult, pediatric, and infant. In 2021, the adult segment garnered approximately 40.0% revenue share. A significant increase in ECMO procedures among adults and high vulnerability of the geriatric population to COVID-19 are anticipated to accelerate product adoption over the study timeframe.

In the regional landscape, the Latin America extracorporeal membrane oxygenation (ECMO) market is estimated to grow at a CAGR of about 3.1% from 2022 to 2030 on account of mounting investment in research & development activities, growing patient population base, and expanding presence of leading players in the LATAM region.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates and working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East & Africa
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Extracorporeal membrane oxygenation industry 360 degree synopsis
    • 2.1.1 Business trends
    • 2.1.2 Modality trends
    • 2.1.3 Application trends
    • 2.1.4 Patient population trends
    • 2.1.5 Regional trends

Chapter 3 Extracorporeal Membrane Oxygenation Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increase in cases of cardiopulmonary disease and respiratory failure in Asia Pacific
      • 3.3.1.2 Technological advancements in ECMO devices
      • 3.3.1.3 Increasing incidence of infectious diseases
      • 3.3.1.4 Rising patient awareness about benefits delivered by extracorporeal membrane oxygenation devices in Latin America
      • 3.3.1.5 Rising government initiatives and programs in Europe
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 High cost of equipment
      • 3.3.2.2 Dearth of skilled professionals
      • 3.3.2.3 Risks related to ECMO devices
  • 3.4 Growth potential analysis
    • 3.4.1 By modality
    • 3.4.2 By application
    • 3.4.3 By patient population
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
  • 3.7 ECMO procedure volume, by region
  • 3.8 Porter's analysis
  • 3.9 Competitive landscape, 2021
  • 3.10 PESTEL analysis

Chapter 4 Extracorporeal Membrane Oxygenation Market, By Modality

  • 4.1 Key segment trends
  • 4.2 Venoarterial (VA)
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Veno-venous (VV)
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.4 Arteriovenous (AV)
    • 4.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Extracorporeal Membrane Oxygenation Market, By Application

  • 5.1 Key segment trends
  • 5.2 Cardiac diseases
    • 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.3 Respiratory diseases
    • 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.4 Extracorporeal cardiopulmonary resuscitation (ECPR)
    • 5.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Extracorporeal Membrane Oxygenation Market, By Patient Population

  • 6.1 Key segment trends
  • 6.2 Infant
    • 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.3 Pediatric
    • 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.4 Adult
    • 6.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 7 Extracorporeal Membrane Oxygenation Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.2.2 Market size, by modality, 2017 - 2030 (USD Million)
    • 7.2.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.2.4 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.5.3 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.6.3 Market size, by patient population, 2017 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.3.2 Market size, by modality, 2017 - 2030 (USD Million)
    • 7.3.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.3.4 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.5.3 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.6.3 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.7.3 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.8.3 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.3.9 Spain
      • 7.3.9.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.9.3 Market size, by patient population, 2017 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.4.2 Market size, by modality, 2017 - 2030 (USD Million)
    • 7.4.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.4.4 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.5.3 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.6.3 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.7.3 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.4.8 Taiwan
      • 7.4.8.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.8.3 Market size, by patient population, 2017 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.5.2 Market size, by modality, 2017 - 2030 (USD Million)
    • 7.5.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.5.4 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.5.3 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.6.3 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.7.3 Market size, by patient population, 2017 - 2030 (USD Million)
  • 7.6 MEA
    • 7.6.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.6.2 Market size, by modality, 2017 - 2030 (USD Million)
    • 7.6.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.6.4 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.5.3 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.6.3 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.6.7 Qatar
      • 7.6.7.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.7.3 Market size, by patient population, 2017 - 2030 (USD Million)
    • 7.6.8 UAE
      • 7.6.8.1 Market size, by modality, 2017 - 2030 (USD Million)
      • 7.6.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.8.3 Market size, by patient population, 2017 - 2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2021
  • 8.2 Abbott Laboratories
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 Fresenius Medical Care AG & Co. KGaA
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Braile Biomedica
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Edwards Lifesciences Corporation
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 ABIOMED
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 EUROSETS
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Getinge AB
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 LivaNova PLC
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Medtronic
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 MicroPort Scientific Corporation
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 NIPRO
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 SB-KAWASUMI LABORATORIES, INC
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis
  • 8.14 Spectrum Medical
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Product landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 SWOT analysis
  • 8.15 Terumo Corporation
    • 8.15.1 Business overview
    • 8.15.2 Financial data
    • 8.15.3 Product landscape
    • 8.15.4 Strategic outlook
    • 8.15.5 SWOT analysis

Data Tables

  • TABLE 1. ECMO market, 2017 - 2021 (USD Million)
  • TABLE 2. ECMO market, 2022 - 2030 (USD Million)
  • TABLE 3. ECMO market, by type, 2017 - 2021 (USD Million)
  • TABLE 4. ECMO market, by type, 2022 - 2030 (USD Million)
  • TABLE 5. ECMO market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 6. ECMO market, by end-use, 2022 - 2030 (USD Million)
  • TABLE 7. ECMO market, by region, 2017 - 2021 (USD Million)
  • TABLE 8. ECMO market, by region, 2022 - 2030 (USD Million)
  • TABLE 9. Industry impact forces
  • TABLE 10. Venoarterial (VA) market size, by region, 2017 - 2021 (USD Million)
  • TABLE 11. Venoarterial (VA) market size, by region, 2022 - 2030 (USD Million)
  • TABLE 12. Veno-venous (VV) market size, by region, 2017 - 2021 (USD Million)
  • TABLE 13. Veno-venous (VV) market size, by region, 2022 - 2030 (USD Million)
  • TABLE 14. Arteriovenous (AV) market size, by region, 2017 - 2021 (USD Million)
  • TABLE 15. Arteriovenous (AV) market size, by region, 2022 - 2030 (USD Million)
  • TABLE 16. Cardiac disease market size, by region, 2017 - 2021 (USD Million)
  • TABLE 17. Cardiac disease market size, by region, 2022 - 2030 (USD Million)
  • TABLE 18. Respiratory disease market size, by region, 2017 - 2021 (USD Million)
  • TABLE 19. Respiratory disease market size, by region, 2022 - 2030 (USD Million)
  • TABLE 20. ECPR market size, by region, 2017 - 2021 (USD Million)
  • TABLE 21. ECPR market size, by region, 2022 - 2030 (USD Million)
  • TABLE 22. Infant market size, by region, 2017 - 2021 (USD Million)
  • TABLE 23. Infant market size, by region, 2022 - 2030 (USD Million)
  • TABLE 24. Pediatric disease market size, by region, 2017 - 2021 (USD Million)
  • TABLE 25. Pediatric disease market size, by region, 2022 - 2030 (USD Million)
  • TABLE 26. Adult disease market size, by region, 2017 - 2021 (USD Million)
  • TABLE 27. Adult disease market size, by region, 2022 - 2030 (USD Million)
  • TABLE 28. North America ECMO market size, by country, 2017 - 2021 (USD Million)
  • TABLE 29. North America ECMO market size, by country, 2022 - 2030 (USD Million)
  • TABLE 30. North America ECMO market size, by Product, 2017 - 2021 (USD Million)
  • TABLE 31. North America ECMO market size, by product, 2022 - 2030 (USD Million)
  • TABLE 32. North America ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 33. North America ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 34. North America ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 35. North America ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 36. North America ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 37. North America ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 38. U.S. ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 39. U.S. ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 40. U.S. ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 41. U.S. ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 42. U.S. ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 43. U.S. ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 44. Canada ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 45. Canada ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 46. Canada ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 47. Canada ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 48. Canada ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 49. Canada ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 50. Europe ECMO market size, by country, 2017 - 2021 (USD Million)
  • TABLE 51. Europe ECMO market size, by country, 2022 - 2030 (USD Million)
  • TABLE 52. Europe ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 53. Europe ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 54. Europe ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 55. Europe ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 56. Europe ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 57. Europe ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 58. Germany ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 59. Germany ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 60. Germany ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 61. Germany ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 62. Germany ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 63. Germany ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 64. UK ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 65. UK ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 66. UK ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 67. UK ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 68. UK ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 69. UK ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 70. France ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 71. France ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 72. France ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 73. France ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 74. France ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 75. France ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 76. Italy ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 77. Italy ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 78. Italy ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 79. Italy ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 80. Italy ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 81. Italy ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 82. Spain ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 83. Spain ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 84. Spain ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 85. Spain ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 86. Spain ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 87. Spain ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 88. Asia Pacific ECMO market size, by country, 2017 - 2021 (USD Million)
  • TABLE 89. Asia Pacific ECMO market size, by country, 2022 - 2030 (USD Million)
  • TABLE 90. Asia Pacific ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 91. Asia Pacific ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 92. Asia Pacific ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 93. Asia Pacific ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 94. Asia Pacific ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 95. Asia Pacific ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 96. India ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 97. India ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 98. India ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 99. India ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 100. India ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 101. India ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 102. China ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 103. China ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 104. China ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 105. China ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 106. China ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 107. China ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 108. Japan ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 109. Japan ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 110. Japan ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 111. Japan ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 112. Japan ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 113. Japan ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 114. Taiwan ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 115. Taiwan ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 116. Taiwan ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 117. Taiwan ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 118. Taiwan ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 119. Taiwan ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 120. Latin America ECMO market size, by country, 2017 - 2021 (USD Million)
  • TABLE 121. Latin America ECMO market size, by country, 2022 - 2030 (USD Million)
  • TABLE 122. Latin America ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 123. Latin America ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 124. Latin America ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 125. Latin America ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 126. Latin America ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 127. Latin America ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 128. Brazil ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 129. Brazil ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 130. Brazil ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 131. Brazil ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 132. Brazil ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 133. Brazil ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 134. Mexico ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 135. Mexico ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 136. Mexico ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 137. Mexico ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 138. Mexico ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 139. Mexico ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 140. Argentina ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 141. Argentina ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 142. Argentina ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 143. Argentina ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 144. Argentina ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 145. Argentina ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 146. Middle East & Africa ECMO market size, by country, 2017 - 2021 (USD Million)
  • TABLE 147. Middle East & Africa ECMO market size, by country, 2022 - 2030 (USD Million)
  • TABLE 148. Middle East & Africa ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 149. Middle East & Africa ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 150. Middle East & Africa ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 151. Middle East & Africa ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 152. Middle East & Africa ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 153. Middle East & Africa ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 154. South Africa ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 155. South Africa ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 156. South Africa ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 157. South Africa ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 158. South Africa ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 159. South Africa ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 160. Saudi Arabia ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 161. Saudi Arabia ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 162. Saudi Arabia ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 163. Saudi Arabia ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 164. Saudi Arabia ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 165. Saudi Arabia ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 166. Qatar ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 167. Qatar ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 168. Qatar ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 169. Qatar ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 170. Qatar ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 171. Qatar ECMO market size, by patient population, 2022 - 2030 (USD Million)
  • TABLE 172. UAE ECMO market size, by modality, 2017 - 2021 (USD Million)
  • TABLE 173. UAE ECMO market size, by modality, 2022 - 2030 (USD Million)
  • TABLE 174. UAE ECMO market size, by application, 2017 - 2021 (USD Million)
  • TABLE 175. UAE ECMO market size, by application, 2022 - 2030 (USD Million)
  • TABLE 176. UAE ECMO market size, by patient population, 2017 - 2021 (USD Million)
  • TABLE 177. UAE ECMO market size, by patient population, 2022 - 2030 (USD Million)

Charts & Figures

  • FIG. 1 Market research approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 ECMO industry 360 degree synopsis
  • FIG. 4 Industry segmentation
  • FIG. 5 Global ECMO market, 2017 - 2030 (USD Million)
  • FIG. 6 Growth potential analysis, by modality
  • FIG. 7 Growth potential analysis, by application
  • FIG. 8 Growth potential analysis, by patient population
  • FIG. 9 Porter's analysis
  • FIG. 10 PESTEL analysis
  • FIG. 11 Key segment trends, by modality
  • FIG. 12 Key segment trends, by application
  • FIG. 13 Key segment trends, by patient population
  • FIG. 14 Key regional trends
  • FIG. 15 Competitive dashboard, 2021